Stay updated on PRTX-100-202 Study in ITP Clinical Trial
Sign up to get notified when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.

Latest updates to the PRTX-100-202 Study in ITP Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer shows Revision: v3.4.3 and no longer shows Revision: v3.4.2, indicating a small site version update.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 and does not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows revision v3.4.1, replacing the previous v3.4.0; this appears to be a minor update with no visible changes to study details or functionality.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor site version change with no effect on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA new unified 'Locations' section was added, listing study sites in California, Massachusetts, Michigan, New York, Ohio, AB, and Leichester, with the revision updated to v3.3.3. The old location-specific subpages and the 'HHS Vulnerability Disclosure' link were removed, reflecting the updated structure.SummaryDifference0.9%

- Check111 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to PRTX-100-202 Study in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.